Akums Drugs and Pharmaceuticals Limited
Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services.
What Akums files
- Others54
- Investor Meet45
- Important34
- Updates15
- Board Meeting12
- PPTs6
Akums Drugs received an ESG rating of '65' from NSE Sustainability. This rating was voluntarily assigned based on publicly available information, highlighting the company's environmental, social, and governance performance.
Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Schedule of meet
Akums Drugs and Pharmaceuticals Limited has cancelled its participation in the Investor/Analysts Meet organized by Antique Stock Broking Limited on August 25, 2026. This decision was made due to medical reasons preventing company personnel from attending the event.
Akums Drugs and Pharmaceuticals Limited will participate in the Antique Healthcare Investor Conference on August 25, 2026, starting at 09:00 AM (IST). This physical group meet will be held at Trident, BKC, Mumbai. No unpublished price sensitive information will be shared during the meet.
Akums reported robust Q1 FY27: revenue grew 13.9% to INR 1,167 Cr, and PAT surged 56.1% to INR 101 Cr. CDMO led growth (+18.6%) with strong volumes and higher API prices. Domestic branded revenue saw 7.3% growth, though margins were impacted by new hires. API losses narrowed, targeting breakeven this...